| Authors: |
Cohen A; Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California, United States of America., Whitfield TW; Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California, United States of America., Kreifeldt M; Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California, United States of America., Koebel P; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Translational Medicine and Neurogenetic Programme, UdS Université de Strasbourg, INSERM U964, CNRS UMR7104, Illkirch, France., Kieffer BL; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Translational Medicine and Neurogenetic Programme, UdS Université de Strasbourg, INSERM U964, CNRS UMR7104, Illkirch, France., Contet C; Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California, United States of America., George O; Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California, United States of America., Koob GF; Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, California, United States of America. |